| Product No | EMEA/H/C/000114 |
|---|---|
| Brand Name | Olansek |
| Nonproprietary Name | olanzapine |
| API | olanzapine |
| ATC Code | N05AH03 |
| Indications | Olanzapine is indicated for the treatment of schizophrenia.Olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Olanzapine is indicated for the treatment of moderate to severe manic episode. Olanzapine has not been demonstrated to prevent recurrence of manic or depressive episodes (see Section 5.1). |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Eli Lilly Co. Ltd. |
| Status | Withdrawn |
| Authorization Date | 1996-10-07 |
| Version | 0 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information